ConductScience.org, home

Paper39384196

Novel H-2Db-restricted CD8 epitope derived from mouse MAGE-type antigen P1A mediates antitumor immunity in C57BL/6 mice.

McAuliffe J and 15 others. J Immunother Cancer, 2024. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. Novel H-2Db-restricted CD8 epitope derived from mouse MAGE-type antigen P1A mediates antitumor immunity in C57BL/6 mice. Papers, record 39384196. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39384196

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Novel H-2Db-restricted CD8 epitope derived from mouse MAGE-type antigen P1A mediates antitumor immunity in C57BL/6 mice.
PubMed
Journal
J Immunother Cancer
PubMed
Year
2024
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
3
iCite
Relative citation ratio, by iCite
0.46, provisional
iCite
Revised in PubMed
2024-10-18
PubMed

Authors16

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1McAuliffe JJameshttps://orcid.org/0000-0002-4858-3191
2Panetti SSilviahttps://orcid.org/0000-0003-0176-7636
3Steffke EEmily
4Wicki AAmandahttps://orcid.org/0009-0001-7779-932X
5Pereira-Almeida VVinnycius
6Noblecourt LLaurine
7Hu YYushu
8Guo SYWShi Yu William
9Lesenfants JJulie
10Ramirez-Valdez RARamiro Andrei
11Chandrasekar VVineethkrishna
12Ahmad MMaryam
13Stroobant VVincent
14Vigneron NNathalie
15Van den Eynde BJBenoit J
16Leung CSKCarol Sze Kihttps://orcid.org/0000-0002-1545-7228

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Epitopes, T-LymphocyteMajor topic
CD8-Positive T-LymphocytesMajor topic
Mice, Inbred C57BLMajor topic
Cancer VaccinesMajor topic
Animals
Mice
Female
Antigens, Neoplasm
Histocompatibility Antigen H-2D
Cell Line, Tumor
H-2 Antigens

Source PubMed

Download CSV of topics

References35

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
130356111Combination of immune checkpoint blockade with DNA cancer vaccine induces potent antitumor immunity against P815 mastocytoma.Sci Rep2018https://conductscience.org/library/papers/30356111PubMed
221282551Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1.J Clin Oncol2011https://conductscience.org/library/papers/21282551PubMed
325538264A pilot trial using lymphocytes genetically engineered with an NY-ESO-1-reactive T-cell receptor: long-term follow-up and correlates with response.Clin Cancer Res2015https://conductscience.org/library/papers/25538264PubMed
429122757CRISPR-mediated TCR replacement generates superior anticancer transgenic T cells.Blood2018https://conductscience.org/library/papers/29122757PubMed
522949370Different affinity windows for virus and cancer-specific T-cell receptors: implications for therapeutic strategies.Eur J Immunol2012https://conductscience.org/library/papers/22949370PubMed
630635236Checkpoint Blockade Immunotherapy Induces Dynamic Changes in PD-1-CD8+ Tumor-Infiltrating T Cells.Immunity2019https://conductscience.org/library/papers/30635236PubMed
71903428The gene coding for a major tumor rejection antigen of tumor P815 is identical to the normal gene of syngeneic DBA/2 mice.J Exp Med1991https://conductscience.org/library/papers/1903428PubMed
816424047De novo induction of a cancer/testis antigen by 5-aza-2'-deoxycytidine augments adoptive immunotherapy in a murine tumor model.Cancer Res2006https://conductscience.org/library/papers/16424047PubMed
935159231Functional Differences between Proteasome Subtypes.Cells2022https://conductscience.org/library/papers/35159231PubMed
1035452075High-efficiency nonviral CRISPR/Cas9-mediated gene editing of human T cells using plasmid donor DNA.J Exp Med2022https://conductscience.org/library/papers/35452075PubMed
1132579133Intratumoral immune activation with TLR4 agonist synergizes with effector T cells to eradicate established murine tumors.NPJ Vaccines2020https://conductscience.org/library/papers/32579133PubMed
1236323434Intravenous administration of viral vectors expressing prostate cancer antigens enhances the magnitude and functionality of CD8+ T cell responses.J Immunother Cancer2022https://conductscience.org/library/papers/36323434PubMed
1316912204Different lineages of P1A-expressing cancer cells use divergent modes of immune evasion for T-cell adoptive therapy.Cancer Res2006https://conductscience.org/library/papers/16912204PubMed
1414522934On the role of unmutated antigens in tumor rejection in mice with unperturbed T-cell repertoires.Cancer Res2003https://conductscience.org/library/papers/14522934PubMed
1527533016T Cell Factor 1-Expressing Memory-like CD8(+) T Cells Sustain the Immune Response to Chronic Viral Infections.Immunity2016https://conductscience.org/library/papers/27533016PubMed
1619008445Batf3 deficiency reveals a critical role for CD8alpha+ dendritic cells in cytotoxic T cell immunity.Science2008https://conductscience.org/library/papers/19008445PubMed
1734479921Heterologous prime-boost vaccination targeting MAGE-type antigens promotes tumor T-cell infiltration and improves checkpoint blockade therapy.J Immunother Cancer2021https://conductscience.org/library/papers/34479921PubMed
1817406263Generation of T-cell receptor retrogenic mice.Nat Protoc2006https://conductscience.org/library/papers/17406263PubMed
1921933959Integrated NY-ESO-1 antibody and CD8+ T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab.Proc Natl Acad Sci U S A2011https://conductscience.org/library/papers/21933959PubMed
2030573690A Pilot Trial of the Combination of Transgenic NY-ESO-1-reactive Adoptive Cellular Therapy with Dendritic Cell Vaccination with or without Ipilimumab.Clin Cancer Res2019https://conductscience.org/library/papers/30573690PubMed

See all 35 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn Papers
41268603Comparative analysis of pan MHC‑I epitopes immunoreactivity on Hantaan virus nucleocapsid protein.Int J Mol Med2026https://conductscience.org/library/papers/41268603

Source PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39384196

GET https://conductscience.org/api/papers/v1/39384196/references?page=2